We can save your selected studies locally in your browser to enhance your experience. This data stays on your device and is not shared with us or third parties. You can clear this data at any time.
Description:
This phase II trial is assessing how 64Cu-ATSM (64Cu-copper(II) diacetylbis(N4-methylthiosemicarbazone)) PET/CT scan could predict neo adjuvant treatment response in rectum cancer locally advanced
Sponsor:
Institut Cancerologie de l'Ouest
Contacts:
Mathilde COLOMBIE, MDmathilde.colombie@ico.unicancer.fr
+33240679900 ext 9501
Nadia ALLAM, PhDnadia.allam@ico.unicancer.fr
+33240679826
Government Study Link:
NCT03951337 - Click here to see study onClinicalTrials.gov